The Chinese firm has pulled back the curtain to expose how the top labs may be building their next-generation models. Now things get interesting.

Yoshua Bengio, often called the 'godfather of AI', warns that the fierce competition between OpenAI and China’s DeepSeek could compromise AI safety.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll hopefully have some AI-designed drugs in clinical trials by the end of the year,

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have

Some AI researchers hailed DeepSeek’s R1 as a breakthrough on the same level as DeepMind’s AlphaZero, a 2017 model that became superhuman at the board games Chess and Go by purely playing against itself and improving, rather than observing any human games.

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical tasks like trip planning. Here's how it works.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The persistent challenge of AI hallucinations - where artificial intelligence systems generate false or misleading information.

The Chinese startup DeepSeek released an AI reasoning model that appears to rival the abilities of a frontier model from OpenAI, the maker of ChatGPT.

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

Aravind Srinivas, CEO of Perplexity AI, is shaping AI and tech, leading a TikTok-ByteDance merger while facing U.S. Green Card delays.